Northrop Grumman (NOC) Director Mark Welsh Sells 95 Shares

What Happened

• Mark A. Welsh III, a director of Northrop Grumman Corporation (NOC), sold a total of 95 shares in open-market transactions on August 3, 2026. The sales were executed in ten tranches at prices between about $544.03 and $554.17, producing aggregate proceeds of approximately $52,015 (average price ~$547.53).
• Individual reported tranches: 8 @ $544.53 ($4,356); 19 @ $545.59 ($10,366); 11 @ $546.42 ($6,011); 31 @ $547.42 ($16,970); 10 @ $548.32 ($5,483); 6 @ $549.50 ($3,297); 2 @ $550.68 ($1,101); 2 @ $552.95 ($1,106); 2 @ $553.90 ($1,108); 4 @ $554.14 ($2,217). These are all sales (code S) reported on Form 4.

Key Details

• Transaction date: August 3, 2026; Form 4 filed August 4, 2026 (timely).
• Price range reported: roughly $544.03 (low) to $554.17 (high); per-tranche weighted averages are shown in the filing (see footnotes).
• Total shares sold: 95; total proceeds: ~$52,015; average price ≈ $547.53.
• Shares owned after transaction: not included in the excerpt provided.
• Notable footnote: Sales were made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Welsh on August 23, 2025 (indicates pre-scheduled trades, not ad hoc trades). Additional footnotes provide per-tranche weighted averages and offer to disclose exact share counts at each price on request.
• Filing timeliness: Report appears timely (filed the day after the trades).

Context

• These were open-market sales under a 10b5-1 plan, which are commonly used by insiders to sell shares on a pre-set schedule; such sales are typically viewed as routine and do not, by themselves, imply a change in insider sentiment.
• For retail investors, purchases by insiders are usually more indicative of bullish conviction than routine sales; this filing documents modest, prearranged sales by a director.